Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DART-HPV: A Phase III Evaluation of De-escalated Adjuvant Radiation Therapy for HPV-Associated Oropharynx Cancer

NCT02908477 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02908477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02908477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DART-HPV: A Phase III Evaluation of De-escalated Adjuvant Radiation Therapy for HPV-Associated Oropharynx Cancer
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
October 3, 2016
Completion date
November 15, 2024
Enrollment
228 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

oropharynx cancer